CASCADIAN THERAPEUTICS INC - COM NEW (CASC)

CUSIP: 14740B606

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM NEW
Total 13F shares
40,614,026
Share change
-1,094,947
Total reported value
$166,109,340
Put/Call ratio
55%
Price per share
$4.09
Number of holders
71
Value change
-$4,027,681
Number of buys
34
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 14740B606?
CUSIP 14740B606 identifies CASC - CASCADIAN THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASCADIAN THERAPEUTICS INC - COM NEW (CASC) as of Q3 2017

As of 30 Sep 2017, CASCADIAN THERAPEUTICS INC - COM NEW (CASC) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,614,026 shares. The largest 10 holders included NEA Management Company, LLC, BAUPOST GROUP LLC/MA, BVF INC/IL, EcoR1 Capital, LLC, BlackRock Inc., Redmile Group, LLC, VANGUARD GROUP INC, venBio Select Advisor LLC, Polar Capital LLP, and Sandia Holdings, LLC. This page lists 71 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.